The BioPharm Brief: Dermatology Data and Autoimmune Innovation
May 27, 07:53 PM
Share
Subscribe
Olezarsen’s latest pancreatitis data, Apogee’s advancing atopic dermatitis program, and Jade Biosciences’ first-in-human autoimmune trial highlight continued momentum in RNA therapeutics, immunology, and antibody development across the biopharmaceutical industry.
